Compare Yonghe Medical Group Co., Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
HKD 857 Million ()
NA (Loss Making)
NA
0.00%
-0.57
-999,999.00%
1.05
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2013)
Net Profit:
0 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.7%
0%
8.7%
6 Months
-33.55%
0%
-33.55%
1 Year
117.39%
0%
117.39%
2 Years
12.36%
0%
12.36%
3 Years
-78.02%
0%
-78.02%
4 Years
-81.82%
0%
-81.82%
5 Years
0%
0%
0.0%
Yonghe Medical Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-1.02%
EBIT to Interest (avg)
-1.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.02
EV to EBIT
-1223.35
EV to EBITDA
-1223.35
EV to Capital Employed
2.72
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.07%
ROE (Latest)
-0.10%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Bearish
Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'13 - YoY
Mar'13
Mar'12
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
0.10
-0.20
150.00%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.40
-0.20
-100.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2013 is 0.00% vs 0.00% in Mar 2012
Consolidated Net Profit
YoY Growth in quarter ended Mar 2013 is -100.00% vs -100.00% in Mar 2012
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
1,963.90
1,642.90
19.54%
Operating Profit (PBDIT) excl Other Income
-127.00
65.30
-294.49%
Interest
59.90
59.60
0.50%
Exceptional Items
-24.20
2.50
-1,068.00%
Consolidate Net Profit
-594.70
-97.70
-508.70%
Operating Profit Margin (Excl OI)
-253.10%
-119.30%
-13.38%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 19.54% vs -37.14% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -508.70% vs -168.95% in Dec 2022
About Yonghe Medical Group Co., Ltd. 
Yonghe Medical Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






